ProfileGDS5822 / ILMN_1257077
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 55% 78% 68% 56% 75% 69% 72% 66% 59% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 124.755
GSM1276600PDAC Late Ablation Control 2116.278
GSM1276601PDAC Late Ablation Control 363.468
GSM1276602PDAC Late Ablation 122.556
GSM1276603PDAC Late Ablation 293.575
GSM1276604PDAC Late Ablation 354.269
GSM1303940PDAC Late Ablation_anti-CTLA4 154.672
GSM1303941PDAC Late Ablation_anti-CTLA4 24966
GSM1303942PDAC Late Ablation_anti-CTLA4 335.359